fluorescein-5-isothiocyanate has been researched along with Parkinsonian Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, S; Bhatnagar, P; Brashket, S; Chaturvedi, RK; Gupta, KC; Kumar, P; Patel, DK; Singh, MP; Singhal, NK; Srivastava, G; Tiwari, MN; Tiwari, SK | 1 |
1 other study(ies) available for fluorescein-5-isothiocyanate and Parkinsonian Disorders
| Article | Year |
|---|---|
Mechanism of Nanotization-Mediated Improvement in the Efficacy of Caffeine Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Active Transport, Cell Nucleus; Animals; Biological Transport; Caffeine; Cell Count; Cell Nucleus; Cell Survival; Dopamine; Dopaminergic Neurons; Drug Carriers; Drug Liberation; Fluorescein-5-isothiocyanate; GAP-43 Protein; Gene Expression Regulation; Lactic Acid; Lipid Peroxidation; Male; Mice; Microglia; Nanoparticles; Neuroprotective Agents; NF-kappa B; Nitrites; Parkinsonian Disorders; Phosphoproteins; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proto-Oncogene Proteins c-akt; RNA, Messenger | 2015 |